Literature DB >> 12134942

Organic anion transporter oatp2-mediated interaction between digoxin and amiodarone in the rat liver.

Takaaki Kodawara1, Satohiro Masuda, Hiroko Wakasugi, Yuichi Uwai, Takahiro Futami, Hideyuki Saito, Takaaki Abe, Ken-ichi Inu.   

Abstract

PURPOSE: The interaction between amiodarone and digoxin has been known to increase serum concentrations of digoxin in humans and rats. In this study, we assessed the molecular mechanism(s) of that drug interaction, focusing on digoxin transport mediated by P-glycoprotein (Pgp) and by rat liver organic anion transporter (oatp2).
METHODS: Digoxin transport by Pgp and oatp2 was assessed using Pgp-overexpressing transfectant LLC-GA5-COL150 monolayers and oatp2-expressing Xenopus oocytes, respectively. The digoxin uptake into the isolated rat hepatocytes was also examined.
RESULTS: Amiodarone (10 microM) inhibited slightly the transcellular transport of digoxin in LLC-GA5-COL150 monolayers, whereas itraconazole (10 microM), a potent Pgp inhibitor, markedly blocked the transport. The digoxin uptake by the isolated rat hepatocytes and by the oatp2-expressing Xenopus oocytes was decreased markedly in the presence of amiodarone but not in the presence of itraconazole. In addition, amiodarone inhibited the oatp2-mediated digoxin uptake in a competitive manner with an apparent inhibition constant value of 1.8 microM.
CONCLUSION: These findings suggest that rat oatp2 rather than Pgp may be one of the interaction sites for digoxin and amiodarone in the liver.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134942     DOI: 10.1023/a:1016184211491

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

1.  Influence of amiodarone on plasma and urine digoxin concentrations.

Authors:  P Douste-Blazy; J L Montastruc; B Bonnet; P Auriol; D Conte; P Bernadet
Journal:  Lancet       Date:  1984-04-21       Impact factor: 79.321

2.  Amiodarone increases plasma digoxin concentrations.

Authors:  J O Moysey; N S Jaggarao; E N Grundy; D A Chamberlain
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-24

3.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

Authors:  T Abe; M Unno; T Onogawa; T Tokui; T N Kondo; R Nakagomi; H Adachi; K Fujiwara; M Okabe; T Suzuki; K Nunoki; E Sato; M Kakyo; T Nishio; J Sugita; N Asano; M Tanemoto; M Seki; F Date; K Ono; Y Kondo; K Shiiba; M Suzuki; H Ohtani; T Shimosegawa; K Iinuma; H Nagura; S Ito; S Matsuno
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

4.  [Effect of itraconazole on digoxin clearance in patients with congestive heart failure].

Authors:  H Wakasugi; R Ishizuka; N Koreeda; I Yano; T Futami; R Nohara; S Sasayama; K Inui
Journal:  Yakugaku Zasshi       Date:  2000-09       Impact factor: 0.302

5.  Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).

Authors:  Y Tanigawara; N Okamura; M Hirai; M Yasuhara; K Ueda; N Kioka; T Komano; R Hori
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

6.  Binding of amiodarone by serum proteins and the effects of drugs, hormones and other interacting ligands.

Authors:  M R Lalloz; P G Byfield; R M Greenwood; R L Himsworth
Journal:  J Pharm Pharmacol       Date:  1984-06       Impact factor: 3.765

7.  Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations.

Authors:  L A Bauer; J R Horn; H Pettit
Journal:  Ther Drug Monit       Date:  1996-02       Impact factor: 3.681

8.  Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.

Authors:  H Wakasugi; I Yano; T Ito; T Hashida; T Futami; R Nohara; S Sasayama; K Inui
Journal:  Clin Pharmacol Ther       Date:  1998-07       Impact factor: 6.875

9.  Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.

Authors:  R Neri; L Mestroni; A Salvi; C Pandullo; F Camerini
Journal:  Am Heart J       Date:  1987-03       Impact factor: 4.749

10.  The digoxin-amiodarone interaction.

Authors:  K Robinson; A Johnston; S Walker; J P Mulrow; W J McKenna; D W Holt
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

View more
  7 in total

Review 1.  Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.

Authors:  Joseph D Ma; Shirley M Tsunoda; Joseph S Bertino; Meghana Trivedi; Keola K Beale; Anne N Nafziger
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

2.  Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.

Authors:  Kerry B Goralski; Georgy Hartmann; Micheline Piquette-Miller; Kenneth W Renton
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

3.  Differential effect of acute hepatic failure on in vivo and in vitro P-glycoprotein functions in the intestine.

Authors:  Ryoko Yumoto; Teruo Murakami; Mikihisa Takano
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

4.  Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney.

Authors:  Tsuyoshi Mikkaichi; Takehiro Suzuki; Tohru Onogawa; Masayuki Tanemoto; Hiroya Mizutamari; Masahiro Okada; Tatsuji Chaki; Satohiro Masuda; Taro Tokui; Nobuaki Eto; Michiaki Abe; Fumitoshi Satoh; Michiaki Unno; Takanori Hishinuma; Ken-Ichi Inui; Sadayoshi Ito; Junichi Goto; Takaaki Abe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

5.  Endothelin-1 reduces p-glycoprotein transport activity in an in vitro model of human adult blood-brain barrier.

Authors:  Alexandra Hembury; Aloïse Mabondzo
Journal:  Cell Mol Neurobiol       Date:  2008-04-01       Impact factor: 5.046

6.  Evidence of active transport involvement in morphine transport via MDCKII and MDCK-PGP cell lines.

Authors:  S O Mashayekhi; M R Sattari; P A Routledge
Journal:  Res Pharm Sci       Date:  2010-07

7.  Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring.

Authors:  Gunilla Englund; Pär Hallberg; Per Artursson; Karl Michaëlsson; Håkan Melhus
Journal:  BMC Med       Date:  2004-04-02       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.